Immtech Pharmaceuticals, Inc.

Immtech Pharmaceuticals aims...

to have a significant positive impact on global health. We plan to achieve this by developing new drug candidates to treat infectious diseases and through the sales and distribution of approved drugs. We are focused on providing healthcare solutions to the global community.

The infectious diseases market represents an estimated US$46 billion in annual sales.

Immtech has exclusive license to a family of compounds covered by patents issued worldwide. Our development efforts have been supported by funding from the National Institutes of Health and the Bill and Melinda Gates Foundation through grants to our Scientific Consortium, led by the University of North Carolina in Chapel Hill(UNC)

Our global focus includes extensive experience and established business relationships in China, a rapidly expanding market for healthcare products and services.

Click here to download the Immtech Corporate Update, June 25, 2008

Company Information

Learn about Immtech Pharmaceuticals:

Company Overview – our history, proprietary technology platform, products and prospects
Executive Team
Board of Directors
Corporate Governance
Career Opportunities
Company FAQs

Investor Center

Learn about investing in Immtech Pharmaceuticals:

The Opportunity – our business model and proprietary technology platform
Technology – mechanisms of action, Scientific Consortium and publications
Pipeline – clinical trials and discovery
SEC Filings
Financial Summary
Investor FAQs

Press Room

go to Press Releases

An audio archive of the Jun-25-2008 conference call is available till July 10, 2008 for download from this link starting on June 26, 2008.

If you need to download Windows Media Player or Real Player, please visit the following links:
Download Windows Media Player
Download Real Player